Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shulamit Wittebol"'
Autor:
Annemiek Broijl, Marie-José Kersten, Wendimagegn Ghidey Alemayehu, Mark-David Levin, Okke de Weerdt, Edo Vellenga, Ellen Meijer, Shulamit Wittebol, Bea C. Tanis, Petra B. Cornelisse, Marian Stevens-Kroef, Gerard M.J. Bos, Pierre W. Wijermans, Henk Lokhorst, Pieter Sonneveld
Publikováno v:
Haematologica, Vol 101, Iss 4 (2016)
Externí odkaz:
https://doaj.org/article/af294774e9884b25b7b24d2b3aedf18c
Autor:
Wendy Deenik, Jeroen J.W.M. Janssen, Bronno van der Holt, Gregor E.G. Verhoef, Willem M. Smit, Marie José Kersten, Simon M.G.J. Daenen, Leo F. Verdonck, Augustin Ferrant, Anton V.M.B. Schattenberg, Pieter Sonneveld, Marinus van Marwijk Kooy, Shulamit Wittebol, Roelof Willemze, Pierre W. Wijermans, H. Berna Beverloo, Bob Löwenberg, Peter J.M. Valk, Gert J. Ossenkoppele, Jan J. Cornelissen
Publikováno v:
Haematologica, Vol 95, Iss 6 (2010)
Background In order to improve the molecular response rate and prevent resistance to treatment, combination therapy with different dosages of imatinib and cytarabine was studied in newly diagnosed patients with chronic myeloid leukemia in the HOVON-5
Externí odkaz:
https://doaj.org/article/52ff014faa724e5c9930e7aea97fd445
Autor:
Jan J, Cornelissen, Bronno, van der Holt, Gregor E G, Verhoef, Mars B, van't Veer, Marinus H J, van Oers, Harry C, Schouten, Gert, Ossenkoppele, Pieter, Sonneveld, Johan, Maertens, Marinus, van Marwijk Kooy, Martijn R, Schaafsma, Pierre W, Wijermans, Douwe H, Biesma, Shulamit, Wittebol, Paul J, Voogt, Joke W, Baars, Pierre, Zachée, Leo F, Verdonck, Bob, Löwenberg, Adriaan W, Dekker
Publikováno v:
Blood, 113(6), 1375-1382. AMER SOC HEMATOLOGY
Blood, 113(6), 1375-1382. American Society of Hematology
Cornelissen, J J, van der Holt, B, Verhoef, G E G, van 't Veer, M B, van Oers, M H J, Schouten, H C, Ossenkoppele, G J, Sonneveld, P, Maertens, J, Kooy, M V, Schaafsma, M R, Wijermans, P W, Biesma, D H, Wittebol, S, Voogt, P J, Baars, J W, Zachee, P, Verdonck, L F, Lowenberg, B & Dekker, A W 2009, ' Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison ', Blood, vol. 113, no. 6, pp. 1375-1382 . https://doi.org/10.1182/blood-2008-07-168625
Blood, 113(6), 1375-1382. American Society of Hematology
Cornelissen, J J, van der Holt, B, Verhoef, G E G, van 't Veer, M B, van Oers, M H J, Schouten, H C, Ossenkoppele, G J, Sonneveld, P, Maertens, J, Kooy, M V, Schaafsma, M R, Wijermans, P W, Biesma, D H, Wittebol, S, Voogt, P J, Baars, J W, Zachee, P, Verdonck, L F, Lowenberg, B & Dekker, A W 2009, ' Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison ', Blood, vol. 113, no. 6, pp. 1375-1382 . https://doi.org/10.1182/blood-2008-07-168625
While commonly accepted in poor-risk acute lymphoblastic leukemia (ALL), the role of allogeneic hematopoietic stem cell transplantation (allo-SCT) is still disputed in adult patients with standard-risk ALL. We evaluated outcome of patients with ALL i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b63c148296ff32cbf0cf7d81ebb7042b
https://research.rug.nl/en/publications/30186619-ddec-4208-932e-23b5606c1067
https://research.rug.nl/en/publications/30186619-ddec-4208-932e-23b5606c1067
